Difference between revisions of "Mefruside"
From Self-sufficiency
m (Stub sorting and placement of stub template(s)) |
m (1 revision) |
(No difference)
|
Latest revision as of 15:45, 19 September 2010
File:Mefruside.png | |
Systematic (IUPAC) name | |
---|---|
4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 7195-27-9 |
ATC code | C03BA05 (WHO) |
PubChem | CID 4047 |
Chemical data | |
Formula | C13H19ClN2O5S2 |
Molar mass | 382.88 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]
It was developed by Bayer A.G. and is sold under the tradename Baycaron.
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- 2Fix
- Diuretics
- Sulfonamides
- Tetrahydrofurans
- Organochlorides
- Cardiovascular system drug stubs